XML 9 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 49,700 $ 30,105 $ 142,039 $ 76,094
General and administrative 7,318 9,337 24,110 25,500
Total operating expenses 57,018 39,442 166,149 101,594
Loss from operations (57,018) (39,442) (166,149) (101,594)
Interest and other income, net 2,096 4,618 7,715 11,984
Net loss (54,922) (34,824) (158,434) (89,610)
Deemed dividend on modification of common stock warrants     (1,857)  
Net loss attributable to common stockholders $ (54,922) $ (34,824) $ (160,291) $ (89,610)
Net loss per share, basic $ (0.37) $ (0.25) $ (1.08) $ (0.68)
Net loss per share, diluted $ (0.37) $ (0.25) $ (1.08) $ (0.68)
Weighted-average shares used in computing net loss per share, basic 149,123,701 139,933,019 148,521,489 130,945,980
Weighted-average shares used in computing net loss per share, diluted 149,123,701 139,933,019 148,521,489 130,945,980